实用癌症杂志
實用癌癥雜誌
실용암증잡지
THE PRACTICAL JOURNAL OF CANCER
2014年
4期
375-378
,共4页
方日%谢金龙%王小文%颜娇贵
方日%謝金龍%王小文%顏嬌貴
방일%사금룡%왕소문%안교귀
肝细胞肝癌%CD31%单核苷酸%多态性
肝細胞肝癌%CD31%單覈苷痠%多態性
간세포간암%CD31%단핵감산%다태성
Hepatocellular carcinoma%CD31%Single nucleotide%Polymorphism
目的:研究CD31基因的单核苷酸多态性和体内血清含量与原发性肝癌的关联性。方法选取160例肝癌患者和160例健康体检者作为观察对象,采用PCR-RFLP技术对CD31基因Leu125Val、Asn563Ser和Gly670Arg单核苷酸多态性进行基因分型,并且采用酶联免疫吸附试验检测血清CD31含量。结果肝癌患者和健康体检者的CD31基因Asn563Ser和Gly670Arg多态性差异不明显(χ2=0.387,P>0.05),而Leu125Val 多态性差异显著(χ2=10.875,P<0.05)。Val等位基因携带者患肝癌的风险是Leu等位基因的1.457倍(OR=1.457,95%CI:1.187~2.186,P=0.001);携带Val等位基因的原发性肝癌患者的血清CD31含量比没有携带的患者要高很多(χ2=10.534,P<0.05)。结合基因型分析表明,CD31基因Leu125Val、Asn563Ser和Gly670Arg单核苷酸多态性具有明显的连锁不平衡,同健康体检者相比, Val-Ser-Arg单倍型携带者罹患肝癌的风险较高(OR=1.487,95%CI:1.092-2.038,P=0.011)。结论 CD31基因的Leu125Val多态性及Val-Ser-Arg单倍型与原发性肝癌具有一定的关联,其中Val等位基因有极大的可能是原发性肝癌的遗传易感基因,携带Val基因型的患者可能会由于CD31基因在体内高度表达而增加罹患肝癌的可能性。
目的:研究CD31基因的單覈苷痠多態性和體內血清含量與原髮性肝癌的關聯性。方法選取160例肝癌患者和160例健康體檢者作為觀察對象,採用PCR-RFLP技術對CD31基因Leu125Val、Asn563Ser和Gly670Arg單覈苷痠多態性進行基因分型,併且採用酶聯免疫吸附試驗檢測血清CD31含量。結果肝癌患者和健康體檢者的CD31基因Asn563Ser和Gly670Arg多態性差異不明顯(χ2=0.387,P>0.05),而Leu125Val 多態性差異顯著(χ2=10.875,P<0.05)。Val等位基因攜帶者患肝癌的風險是Leu等位基因的1.457倍(OR=1.457,95%CI:1.187~2.186,P=0.001);攜帶Val等位基因的原髮性肝癌患者的血清CD31含量比沒有攜帶的患者要高很多(χ2=10.534,P<0.05)。結閤基因型分析錶明,CD31基因Leu125Val、Asn563Ser和Gly670Arg單覈苷痠多態性具有明顯的連鎖不平衡,同健康體檢者相比, Val-Ser-Arg單倍型攜帶者罹患肝癌的風險較高(OR=1.487,95%CI:1.092-2.038,P=0.011)。結論 CD31基因的Leu125Val多態性及Val-Ser-Arg單倍型與原髮性肝癌具有一定的關聯,其中Val等位基因有極大的可能是原髮性肝癌的遺傳易感基因,攜帶Val基因型的患者可能會由于CD31基因在體內高度錶達而增加罹患肝癌的可能性。
목적:연구CD31기인적단핵감산다태성화체내혈청함량여원발성간암적관련성。방법선취160례간암환자화160례건강체검자작위관찰대상,채용PCR-RFLP기술대CD31기인Leu125Val、Asn563Ser화Gly670Arg단핵감산다태성진행기인분형,병차채용매련면역흡부시험검측혈청CD31함량。결과간암환자화건강체검자적CD31기인Asn563Ser화Gly670Arg다태성차이불명현(χ2=0.387,P>0.05),이Leu125Val 다태성차이현저(χ2=10.875,P<0.05)。Val등위기인휴대자환간암적풍험시Leu등위기인적1.457배(OR=1.457,95%CI:1.187~2.186,P=0.001);휴대Val등위기인적원발성간암환자적혈청CD31함량비몰유휴대적환자요고흔다(χ2=10.534,P<0.05)。결합기인형분석표명,CD31기인Leu125Val、Asn563Ser화Gly670Arg단핵감산다태성구유명현적련쇄불평형,동건강체검자상비, Val-Ser-Arg단배형휴대자리환간암적풍험교고(OR=1.487,95%CI:1.092-2.038,P=0.011)。결론 CD31기인적Leu125Val다태성급Val-Ser-Arg단배형여원발성간암구유일정적관련,기중Val등위기인유겁대적가능시원발성간암적유전역감기인,휴대Val기인형적환자가능회유우CD31기인재체내고도표체이증가리환간암적가능성。
Objective To investigate the association of single nucleotide polymorphisms ( SNPs) of CD31 and serum level with hepatocellular carcinoma(HCC).Methods Three single nucleotide polymorphisms Leu125Val,Asn563Ser and Gly670Arg of CD31 were analyzed using polymerase chain reaction-restriction fragment length polymorphism ( PCR-RFLP ) , and the serum level of CD31 was determined by enzyme-linked immunosorbent assay ( ELISA) in 160 HCC patients and 160 healthy patients .Re-sults The CD31 gene Asn563Ser and Gly670Arg polymorphisms had no significant difference between the HCC group and the control group(χ2 =0.387,P>0.05),but the CD31 gene Leu125Val polymorphism of the 2 groups had significant difference (χ2=10.875,P<0.05).The relative risk of HCC of Val allele was 1.457 times that of the Leu allele carriers(OR=1.457,95%CI:1.187~2.186,P=0.001);Serum level of CD31 of Val allele carriers was significantly higher than that of no carriers (χ2 =10.534,P<0.05).Genotype analysis showed that CD31 gene Leu125Val,Asn563Ser and Gly670Arg polymorphisms had strong linkage disequilibrium ,the Val-Ser-Arg haplotype was associated with a high risk of HCC as compared with the healthy patients (OR=1.487,95%CI:1.092-2.038,P=0.011).Conclusion CD31 gene Leu125Val polymorphism and its Val-Ser-Arg haplo-type are associated with HCC ,and Val allele is very likely an important genetic susceptibility gene for HCC .CD31 Val allele carri-ers may subject to higher risk of HCC with enhanced CD 31 expression .